ZOLL Thermogard XP IVTM Physician Manual - Manual (Page 30)

ZOLL IVTM™ System Physicians' Manual
600248-001 Rev 3 29
Table 11. Summary of Recommended Frequency of Replacements for Catheters,Dressings,
Administration Sets, and Fluids
Device Replacement and
relocation of
device Replacement of
catheter-site
dressing Replacement of
administration
sets Hang time for
parenteral fluids
Central venous
catheters
including
peripherally
inserted central
catheters and
hemodialysis
Catheters. In adults, do not
replace catheters
routinely to
prevent catheter-
related infection.
In pediatric
patients, no
recommendation
for the frequency
of catheter
replacement.
Replace
disposable or
reusable
transducers at 72-
hour intervals.
Replace
continuous flush
device at the time
the transducer is
replaced.
Replace gauze
dressings every 2
days and
transpar-ent
dressings every 7
days on short-
term catheters.
Replace the
dressing when
the catheter is
replaced, or when
the dressing
becomes damp,
loosened, or
soiled, or when
inspection of the
site is necessary. Replace
intravenous
tubing and add-
on devices no
more frequently
than at 72-hour
intervals. Replace
tubing used to
administer blood
products or lipid
emulsions within
24 hours of
initiating the
infusion. No
recommendation
for the hang time
of intravenous
fluids, including
nonlipid-
containing
parenteral
nutrition fluids.
Complete
infusions of lipid-
containing fluids
within 24 hours of
hanging the fluid.
Given the above, the following points are worth noting about IVTM heat exchange
catheters:
1. As with any central line, the primary method for the prevention of CR-BSI
with IVTM catheters is to employ a thorough asceptic technique during
insertion and with handling of the insertion site and catheter blood path
components..
2. IVTM catheters are labeled for indwelling use for 2-7 days depending upon
model.
3. The Start-Up Kit, with its associated tubing, is supplied sterile. Once primed,
using an asceptic technique, it should remain sterile. Unless there is a
breach of the catheter balloon or manifold there is no infection risk to the
patient from this fluid as it does not enter the patient.
4. ZOLL supplies Chlorhexidine Gluconate skin preparations and a
Chlorhexidine Gluconate insertion site patch to help reduce the risk of skin
commensals colonizing the shaft.